Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDEnfusion Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | $0.09 | $0.09 | $0.09 |
| Q2 2026 | 1 | $0.09 | $0.09 | $0.09 |
| Q3 2026 | 1 | $0.10 | $0.10 | $0.10 |
| Q4 2026 | 1 | $0.10 | $0.10 | $0.10 |
| Q1 2027 | 1 | $0.09 | $0.09 | $0.09 |
| Q2 2027 | 1 | $0.09 | $0.09 | $0.09 |
| Q3 2027 | 1 | $0.10 | $0.10 | $0.10 |
| Q4 2027 | 1 | $0.12 | $0.12 | $0.12 |
Enfusion Inc Earnings Date And Information
Enfusion Inc last posted its earnings results on Thursday, May 8th, 2025. The company reported $-0.01 earnings per share for the quarter, missing analysts' consensus estimates of $0.06 by $0.07. The company had revenue of 52.94 M for the quarter and had revenue of 201.61 M for the year. Enfusion Inc has generated $0 earnings per share over the last year ($0.0134 diluted earnings per share) and currently has a price-to-earnings ratio of 660.32. Enfusion Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Enfusion Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/03/2025 | Q4 2024 | $0.07 | $0.00 | -0.07 | $54.32 M | $52.94 M |
| 11/04/2024 | Q3 2024 | $0.06 | $0.02 | -0.04 | $52.17 M | $51.17 M |
| 08/06/2024 | Q2 2024 | $0.06 | $0.02 | -0.04 | $49.97 M | $49.46 M |
| 05/09/2024 | Q1 2024 | $0.04 | -$0.01 | -0.04 | $47.62 M | $48.05 M |
| 03/12/2024 | Q4 2023 | $0.06 | $0.01 | -0.05 | $45.17 M | $46.49 M |
| 11/07/2023 | Q3 2023 | $0.05 | $0.02 | -0.03 | $43.90 M | $44.36 M |
| 08/08/2023 | Q2 2023 | $0.05 | $0.01 | -0.04 | $44.59 M | $42.72 M |
| 05/09/2023 | Q1 2023 | $0.04 | $0.05 | 0.01 | $41.76 M | $40.97 M |
| 03/10/2023 | Q4 2022 | N/A | $0.01 | N/A | $40.01 M | $40.52 M |
| 11/10/2022 | Q3 2022 | $0.01 | $0.03 | 0.02 | $38.64 M | $39.15 M |
| 08/10/2022 | Q2 2022 | N/A | -$0.03 | N/A | $35.58 M | $36.54 M |
| 05/13/2022 | Q1 2022 | N/A | -$0.16 | N/A | $33.04 M | $34.14 M |
| 03/30/2022 | Q4 2021 | N/A | -$3.53 | N/A | $30.41 M | $31.85 M |
| 12/03/2021 | Q3 2021 | N/A | $0.05 | N/A | N/A | $29.05 M |
| 06/29/2021 | Q2 2021 | N/A | $0.07 | N/A | N/A | $26.45 M |
| 03/31/2021 | Q1 2021 | N/A | $0.06 | N/A | N/A | $24.35 M |
| 12/30/2020 | Q4 2020 | N/A | -$0.19 | N/A | N/A | $22.66 M |
| 09/29/2020 | Q3 2020 | N/A | $0.09 | N/A | N/A | $19.79 M |
| 06/29/2020 | Q2 2020 | N/A | $0.08 | N/A | N/A | $18.56 M |
| 03/30/2020 | Q1 2020 | N/A | $0.06 | N/A | N/A | $18.56 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Enfusion Inc Earnings: FAQ's
The conference call for Enfusion Inc's latest earnings report can be listened to online.
The conference call transcript for Enfusion Inc's latest earnings report can be read online.
Enfusion Inc (:ENFN) has a recorded annual revenue of $201.61 M.
Enfusion Inc (:ENFN) has a recorded net income of $2.82 M.Enfusion Inc has generated $0.0188 earnings per share over the last four quarters.
Enfusion Inc (:ENFN) has a price-to-earnings ratio of 660.32 and price/earnings-to-growth ratio is -47.82.